首页 > 最新文献

Fukushima Journal of Medical Science最新文献

英文 中文
Relationship between quality of life before treatment and survival in patients with hematological malignancies: A meta-analysis. 恶性血液病患者治疗前生活质量与生存的关系:一项荟萃分析。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-19 Epub Date: 2025-02-08 DOI: 10.5387/fms.24-00042
Keiichi Osaki, Shinichiro Morishita, Jiro Nakano, Junichiro Inoue, Taro Okayama, Katsuyoshi Suzuki, Takashi Tanaka, Takuya Fukushima

This meta-analysis aimed to investigate the impact of pretreatment quality of life (QoL) on overall survival (OS) in patients with hematological malignancies. The observational studies with relationship between QoL and OS in patients undergoing either hematopoietic stem cell transplantation (HSCT) or chemotherapy were collected. Stratification by treatment was performed to examine the association between QoL and OS. Six articles were included in the analysis. Overall, significant associations with OS were observed for global QoL (hazard ratio [HR] = 1.04, 95% confidence interval [CI] = 1.01-1.08), physical QoL (HR = 1.06, 95% CI:1.02-1.10), and social QoL (HR = 1.02, 95% CI: 1.00-1.03). When stratified by treatment, HSCT showed significant associations between OS and both global QoL (HR = 1.05, 95% CI:1.00-1.11) and physical QoL (HR = 1.03, 95% CI:1.00-1.06). For chemotherapy, significant associations were also observed between OS and global QoL (HR = 1.04, 95% CI:1.00-1.09), physical QoL (HR = 1.08, 95% CI:1.00-1.17), role QoL (HR = 1.02, 95% CI:1.00-1.04), and social QoL (HR = 1.02, 95% CI:1.00-1.04). No significant associations were observed regarding emotional QoL, which was only analyzed in HSCT. The factors influencing OS may vary depending on the treatment, emphasizing the importance of recognizing QoL from the pretreatment stage.

本荟萃分析旨在探讨预处理生活质量(QoL)对血液恶性肿瘤患者总生存期(OS)的影响。收集了造血干细胞移植(HSCT)或化疗患者生活质量与OS关系的观察性研究。通过治疗分层来检查生活质量和OS之间的关系。六篇文章被纳入分析。总体而言,总体生活质量(风险比[HR] = 1.04, 95%可信区间[CI] = 1.01-1.08)、身体生活质量(HR = 1.06, 95% CI:1.02-1.10)和社会生活质量(HR = 1.02, 95% CI: 1.00-1.03)与OS存在显著相关性。当按治疗分层时,HSCT显示OS与总体生活质量(HR = 1.05, 95% CI:1.00-1.11)和物理生活质量(HR = 1.03, 95% CI:1.00-1.06)之间存在显著关联。对于化疗,也观察到OS与总体生活质量(HR = 1.04, 95% CI:1.00-1.09)、身体生活质量(HR = 1.08, 95% CI:1.00-1.17)、角色生活质量(HR = 1.02, 95% CI:1.00-1.04)和社会生活质量(HR = 1.02, 95% CI:1.00-1.04)之间存在显著关联。在情绪生活质量方面未观察到显著关联,仅在HSCT中分析。影响OS的因素可能因治疗而异,强调从预处理阶段识别QoL的重要性。
{"title":"Relationship between quality of life before treatment and survival in patients with hematological malignancies: A meta-analysis.","authors":"Keiichi Osaki, Shinichiro Morishita, Jiro Nakano, Junichiro Inoue, Taro Okayama, Katsuyoshi Suzuki, Takashi Tanaka, Takuya Fukushima","doi":"10.5387/fms.24-00042","DOIUrl":"10.5387/fms.24-00042","url":null,"abstract":"<p><p>This meta-analysis aimed to investigate the impact of pretreatment quality of life (QoL) on overall survival (OS) in patients with hematological malignancies. The observational studies with relationship between QoL and OS in patients undergoing either hematopoietic stem cell transplantation (HSCT) or chemotherapy were collected. Stratification by treatment was performed to examine the association between QoL and OS. Six articles were included in the analysis. Overall, significant associations with OS were observed for global QoL (hazard ratio [HR] = 1.04, 95% confidence interval [CI] = 1.01-1.08), physical QoL (HR = 1.06, 95% CI:1.02-1.10), and social QoL (HR = 1.02, 95% CI: 1.00-1.03). When stratified by treatment, HSCT showed significant associations between OS and both global QoL (HR = 1.05, 95% CI:1.00-1.11) and physical QoL (HR = 1.03, 95% CI:1.00-1.06). For chemotherapy, significant associations were also observed between OS and global QoL (HR = 1.04, 95% CI:1.00-1.09), physical QoL (HR = 1.08, 95% CI:1.00-1.17), role QoL (HR = 1.02, 95% CI:1.00-1.04), and social QoL (HR = 1.02, 95% CI:1.00-1.04). No significant associations were observed regarding emotional QoL, which was only analyzed in HSCT. The factors influencing OS may vary depending on the treatment, emphasizing the importance of recognizing QoL from the pretreatment stage.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"73-84"},"PeriodicalIF":0.7,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143256995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent topics in diagnosis and treatment of malignant spinal tumors. 恶性脊柱肿瘤的诊断与治疗。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-19 Epub Date: 2025-02-08 DOI: 10.5387/fms.24-00008
Yoshihiro Matsumoto

The diagnosis and treatment of malignant spinal tumors are complex and require an integrated approach known as Jaffe's triangle. This review discusses recent topics in the diagnosis and treatment of primary and metastatic malignant spinal tumors. Integrated diagnostic methods, including the development of a dumbbell scoring system for benign-malignant differentiation and the use of positron emission tomography and magnetic resonance imaging (PET-MRI), have improved diagnostic accuracy. Curative resection techniques such as vertebrectomy, sagittal resection, and posterior resection are crucial for primary malignant tumors. Heavy particle radiation therapy, such as carbon-ion radiotherapy, shows promise against radiation-resistant tumors, whereas novel drug therapies, such as denosumab, are effective for giant cell tumors of the bone arising in the spine. For metastatic spinal tumors, the collaborative efforts of the Bone Metastasis Cancer Board and minimally invasive spine stabilization have expanded surgical indications and improved patient outcomes. The treatment system has shifted towards preventive surgery and outpatient management, aiming to maintain quality of life and continue chemotherapy. Interdisciplinary collaboration is essential for improving treatment outcomes in both primary and metastatic malignant spinal tumors.Primary malignant spinal cord tumors (PMST) and metastatic spinal tumors (MST) are among the most difficult areas of orthopedic surgery. Their diagnosis and treatment require multidisciplinary diagnostic and therapeutic strategies that integrate knowledge and skills in orthopedics, pathology, and diagnostic radiology (the so-called Jaffe triangle), as well as in clinical oncology and tumor biology, which have made remarkable progress in recent years. Here, we review recent topics related to the diagnosis and treatment of PMST and MST.

恶性脊柱肿瘤的诊断和治疗是复杂的,需要一种称为Jaffe三角的综合方法。本文就原发性和转移性恶性脊柱肿瘤的诊断和治疗作一综述。综合诊断方法,包括哑铃评分系统的发展,良恶性鉴别和正电子发射断层扫描和磁共振成像(PET-MRI)的使用,提高了诊断的准确性。根治性切除技术如椎体切除、矢状切除和后路切除是治疗原发性恶性肿瘤的关键。重粒子放射治疗,如碳离子放射治疗,显示出治疗耐辐射肿瘤的希望,而新型药物治疗,如denosumab,对脊柱中产生的骨巨细胞肿瘤有效。对于转移性脊柱肿瘤,骨转移癌委员会和微创脊柱稳定的合作努力扩大了手术指征,改善了患者的预后。治疗系统已转向预防性手术和门诊管理,旨在维持生活质量和继续化疗。跨学科合作对于改善原发性和转移性恶性脊柱肿瘤的治疗效果至关重要。原发性脊髓恶性肿瘤(PMST)和转移性脊髓肿瘤(MST)是骨科手术中最困难的领域之一。他们的诊断和治疗需要多学科的诊断和治疗策略,整合骨科,病理学,诊断放射学(所谓的Jaffe三角)以及临床肿瘤学和肿瘤生物学的知识和技能,近年来取得了显着的进展。在这里,我们回顾了最近与PMST和MST的诊断和治疗相关的话题。
{"title":"Recent topics in diagnosis and treatment of malignant spinal tumors.","authors":"Yoshihiro Matsumoto","doi":"10.5387/fms.24-00008","DOIUrl":"10.5387/fms.24-00008","url":null,"abstract":"<p><p>The diagnosis and treatment of malignant spinal tumors are complex and require an integrated approach known as Jaffe's triangle. This review discusses recent topics in the diagnosis and treatment of primary and metastatic malignant spinal tumors. Integrated diagnostic methods, including the development of a dumbbell scoring system for benign-malignant differentiation and the use of positron emission tomography and magnetic resonance imaging (PET-MRI), have improved diagnostic accuracy. Curative resection techniques such as vertebrectomy, sagittal resection, and posterior resection are crucial for primary malignant tumors. Heavy particle radiation therapy, such as carbon-ion radiotherapy, shows promise against radiation-resistant tumors, whereas novel drug therapies, such as denosumab, are effective for giant cell tumors of the bone arising in the spine. For metastatic spinal tumors, the collaborative efforts of the Bone Metastasis Cancer Board and minimally invasive spine stabilization have expanded surgical indications and improved patient outcomes. The treatment system has shifted towards preventive surgery and outpatient management, aiming to maintain quality of life and continue chemotherapy. Interdisciplinary collaboration is essential for improving treatment outcomes in both primary and metastatic malignant spinal tumors.Primary malignant spinal cord tumors (PMST) and metastatic spinal tumors (MST) are among the most difficult areas of orthopedic surgery. Their diagnosis and treatment require multidisciplinary diagnostic and therapeutic strategies that integrate knowledge and skills in orthopedics, pathology, and diagnostic radiology (the so-called Jaffe triangle), as well as in clinical oncology and tumor biology, which have made remarkable progress in recent years. Here, we review recent topics related to the diagnosis and treatment of PMST and MST.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"85-95"},"PeriodicalIF":0.7,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143256947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful cord blood transplantation for a unique case of bone marrow failure presenting t(2;19)(p23;q13.3) translocation suggesting disruption of DPY30. 成功的脐带血移植治疗一例骨髓衰竭,表现为t(2;19)(p23;q13.3)易位,提示DPY30的破坏。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-19 Epub Date: 2025-02-08 DOI: 10.5387/fms.24-00044
Yuki Sato, Daisuke Koyama, Shoki Yamada, Naomi Kamei, Koichiro Fukuchi, Kengo Suzuki, Yasuhiro Uchida, Manabu Suzuki, Masahiko Fukatsu, Yuko Hashimoto, Takayuki Ikezoe

H3K4 methylation, primarily mediated by MLL family proteins, plays a pivotal role in the epigenetic regulation of gene transcription. Among the MLL family, KMT2A is known for its critical role in hematopoiesis. MLL family proteins feature C-terminal SET catalytic domains, requiring the formation of MLL complexes with proteins like DPY30 to maximize their enzymatic activity. Deletion of DPY30 results in a significant reduction in H3K4me1, H3K4me2, and H3K4me3 levels in bone marrow (BM) cells, underscoring the essential role of DPY30 in facilitating optimal catalytic activity within MLL family complexes. Here, we present a unique case of myelodysplastic neoplasms (MDS) associated with a novel t(2;19)(p23;q13.3) translocation. A 22-year-old pregnant woman initially sought consultation due to thrombocytopenia, which temporarily improved following a miscarriage. However, she later presented with progressive pancytopenia. RNA sequencing analysis of BM mononuclear cells using STAR-Fusion revealed the translocation breakpoint on chromosomes, resulting in the disruption of the DPY30 and CEACAM6 genes. BM failure showed marked improvement following cord blood transplantation. This case represents a novel form of MDS associated with the disruption of the DPY30 gene. Our findings underscore the importance of considering early hematopoietic stem cell transplantation for MDS cases attributed to DPY30 dysfunction.

H3K4甲基化主要由MLL家族蛋白介导,在基因转录的表观遗传调控中起关键作用。在MLL家族中,KMT2A因其在造血中的关键作用而闻名。MLL家族蛋白具有c端SET催化结构域,需要与DPY30等蛋白形成MLL复合物以最大化其酶活性。DPY30的缺失导致骨髓(BM)细胞中H3K4me1、H3K4me2和H3K4me3水平的显著降低,强调了DPY30在促进MLL家族复合物中最佳催化活性方面的重要作用。在这里,我们提出了一个独特的病例骨髓增生异常肿瘤(MDS)与一个新的t(2;19)(p23;q13.3)易位相关。一名22岁的孕妇最初因血小板减少症寻求咨询,在流产后暂时改善。然而,她后来出现进行性全血细胞减少症。利用STAR-Fusion对BM单核细胞进行RNA测序分析,发现染色体上的易位断点导致DPY30和CEACAM6基因断裂。脐带血移植后骨髓衰竭明显改善。该病例代表了一种与DPY30基因破坏相关的新型MDS。我们的研究结果强调了考虑早期造血干细胞移植对于DPY30功能障碍导致的MDS病例的重要性。
{"title":"Successful cord blood transplantation for a unique case of bone marrow failure presenting t(2;19)(p23;q13.3) translocation suggesting disruption of DPY30.","authors":"Yuki Sato, Daisuke Koyama, Shoki Yamada, Naomi Kamei, Koichiro Fukuchi, Kengo Suzuki, Yasuhiro Uchida, Manabu Suzuki, Masahiko Fukatsu, Yuko Hashimoto, Takayuki Ikezoe","doi":"10.5387/fms.24-00044","DOIUrl":"10.5387/fms.24-00044","url":null,"abstract":"<p><p>H3K4 methylation, primarily mediated by MLL family proteins, plays a pivotal role in the epigenetic regulation of gene transcription. Among the MLL family, KMT2A is known for its critical role in hematopoiesis. MLL family proteins feature C-terminal SET catalytic domains, requiring the formation of MLL complexes with proteins like DPY30 to maximize their enzymatic activity. Deletion of DPY30 results in a significant reduction in H3K4me1, H3K4me2, and H3K4me3 levels in bone marrow (BM) cells, underscoring the essential role of DPY30 in facilitating optimal catalytic activity within MLL family complexes. Here, we present a unique case of myelodysplastic neoplasms (MDS) associated with a novel t(2;19)(p23;q13.3) translocation. A 22-year-old pregnant woman initially sought consultation due to thrombocytopenia, which temporarily improved following a miscarriage. However, she later presented with progressive pancytopenia. RNA sequencing analysis of BM mononuclear cells using STAR-Fusion revealed the translocation breakpoint on chromosomes, resulting in the disruption of the DPY30 and CEACAM6 genes. BM failure showed marked improvement following cord blood transplantation. This case represents a novel form of MDS associated with the disruption of the DPY30 gene. Our findings underscore the importance of considering early hematopoietic stem cell transplantation for MDS cases attributed to DPY30 dysfunction.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"129-134"},"PeriodicalIF":0.7,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079049/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of simultaneous pancreas-kidney transplantation: experience of a single center. 同时胰肾移植的临床结果:单一中心的经验。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-19 Epub Date: 2025-02-08 DOI: 10.5387/fms.24-00052
Akira Kenjo, Naoya Sato, Takayasu Azuma, Atsushi Nishimagi, Shigeyuki Tsukida, Seiko Suzushino, Makoto Muto, Hiroto Chiba, Junichiro Watanabe, Junichiro Haga, Yasuhide Kofunato, Teruhide Ishigame, Takashi Kimura, Shigeru Marubashi

This study evaluated the outcomes of simultaneous pancreas-kidney transplantation (SPK) at Fukushima Medical University between 2001 and 2024. We retrospectively reviewed ten adult patients who underwent SPK. We aimed to clarify the important aspects of patient management in patients undergoing SPK, focusing on perioperative outcomes and long-term complications.The median postoperative observation period was 1,968 days. Postoperative complications were observed in all patients. Most were classified as Clavien-Dindo (CD) grade I or II, but major complications, including CD grade IIIa or higher, were observed in four patients (40%) with zero mortality. Despite the loss of one kidney graft due to primary non-function, the 5-year survival rates for both patients and pancreatic grafts remained at 100%. However, there was one case each of pancreatic graft loss, kidney graft loss, and patient death after 5 years post-transplantation, all attributed to late-onset complications, including recurrent type 1 diabetes, focal segmental glomerulosclerosis, and cardiovascular disease.The short-term outcomes of SPK at our institution were favorable, with a trend toward a reduction in the comprehensive complication index (CCI) observed in the latter five cases compared with the first five cases, suggesting potential improvements in perioperative management. Long-term monitoring and collaboration with physicians are essential to enhance patient outcomes. .

本研究评估了2001年至2024年间福岛医科大学同步胰肾移植(SPK)的结果。我们回顾性分析了10例接受SPK的成人患者。我们的目的是阐明SPK患者管理的重要方面,重点是围手术期结果和长期并发症。术后中位观察期1968 d。所有患者均出现术后并发症。大多数患者被分类为Clavien-Dindo (CD) I级或II级,但在4例(40%)患者中观察到主要并发症,包括CD IIIa级或更高,死亡率为零。尽管由于原发性无功能而失去了一个肾移植,但患者和胰腺移植的5年生存率仍然为100%。然而,移植5年后胰腺移植丢失、肾脏移植丢失和患者死亡各1例,均归因于迟发性并发症,包括复发性1型糖尿病、局灶节段性肾小球硬化和心血管疾病。我院SPK的短期预后良好,与前5例相比,后5例患者的综合并发症指数(CCI)有降低的趋势,提示围手术期管理有改善的潜力。长期监测和与医生合作对提高患者的治疗效果至关重要。
{"title":"Clinical outcomes of simultaneous pancreas-kidney transplantation: experience of a single center.","authors":"Akira Kenjo, Naoya Sato, Takayasu Azuma, Atsushi Nishimagi, Shigeyuki Tsukida, Seiko Suzushino, Makoto Muto, Hiroto Chiba, Junichiro Watanabe, Junichiro Haga, Yasuhide Kofunato, Teruhide Ishigame, Takashi Kimura, Shigeru Marubashi","doi":"10.5387/fms.24-00052","DOIUrl":"10.5387/fms.24-00052","url":null,"abstract":"<p><p>This study evaluated the outcomes of simultaneous pancreas-kidney transplantation (SPK) at Fukushima Medical University between 2001 and 2024. We retrospectively reviewed ten adult patients who underwent SPK. We aimed to clarify the important aspects of patient management in patients undergoing SPK, focusing on perioperative outcomes and long-term complications.The median postoperative observation period was 1,968 days. Postoperative complications were observed in all patients. Most were classified as Clavien-Dindo (CD) grade I or II, but major complications, including CD grade IIIa or higher, were observed in four patients (40%) with zero mortality. Despite the loss of one kidney graft due to primary non-function, the 5-year survival rates for both patients and pancreatic grafts remained at 100%. However, there was one case each of pancreatic graft loss, kidney graft loss, and patient death after 5 years post-transplantation, all attributed to late-onset complications, including recurrent type 1 diabetes, focal segmental glomerulosclerosis, and cardiovascular disease.The short-term outcomes of SPK at our institution were favorable, with a trend toward a reduction in the comprehensive complication index (CCI) observed in the latter five cases compared with the first five cases, suggesting potential improvements in perioperative management. Long-term monitoring and collaboration with physicians are essential to enhance patient outcomes. .</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"119-128"},"PeriodicalIF":0.7,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143256949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three cases of gastrointestinal stromal tumors with metaiodobenzylguanidine (MIBG) accumulation. 胃肠道间质瘤合并甲氧十二苄基胍积累3例。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-19 Epub Date: 2025-02-08 DOI: 10.5387/fms.24-00003
Honami Kobiyama, Shiro Ishii, Yumi Saito, Natsumi Kawamoto, Shigeyasu Sugawara, Hiroshi Ito

Meta-iodobenzylguanidine (MIBG) is an analog of norepinephrine and guanethidine, and MIBG scintigraphy is useful to diagnose tumors of the sympathetic nervous system, such as pheochromocytoma, paraganglioma, and neuroblastoma. To date, there have been few reports of MIBG accumulation in gastrointestinal stromal tumors (GISTs), so the mechanism and frequency of MIBG accumulation in GISTs are unknown. Herein, we report and discuss three cases of GIST in which scintigraphy that was performed to exclude pheochromocytoma showed MIBG accumulation.

间碘苄基胍(MIBG)是去甲肾上腺素和胍乙啶的类似物,MIBG显像可用于诊断交感神经系统肿瘤,如嗜铬细胞瘤、副神经节瘤和神经母细胞瘤。迄今为止,关于胃肠道间质瘤(gist)中MIBG积累的报道较少,因此胃肠道间质瘤中MIBG积累的机制和频率尚不清楚。在此,我们报告并讨论了三例GIST病例,其中通过显像排除嗜铬细胞瘤显示MIBG积累。
{"title":"Three cases of gastrointestinal stromal tumors with metaiodobenzylguanidine (MIBG) accumulation.","authors":"Honami Kobiyama, Shiro Ishii, Yumi Saito, Natsumi Kawamoto, Shigeyasu Sugawara, Hiroshi Ito","doi":"10.5387/fms.24-00003","DOIUrl":"10.5387/fms.24-00003","url":null,"abstract":"<p><p>Meta-iodobenzylguanidine (MIBG) is an analog of norepinephrine and guanethidine, and MIBG scintigraphy is useful to diagnose tumors of the sympathetic nervous system, such as pheochromocytoma, paraganglioma, and neuroblastoma. To date, there have been few reports of MIBG accumulation in gastrointestinal stromal tumors (GISTs), so the mechanism and frequency of MIBG accumulation in GISTs are unknown. Herein, we report and discuss three cases of GIST in which scintigraphy that was performed to exclude pheochromocytoma showed MIBG accumulation.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"135-139"},"PeriodicalIF":0.7,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Agents and Patient Characteristics Affecting Metabolism of Thiopurines in Patients with Inflammatory Bowel Disease. 影响炎症性肠病患者硫嘌呤代谢的治疗药物和患者特征。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 Epub Date: 2025-01-07 DOI: 10.5387/fms.24-00009
Masato Aizawa, Kohei Suzuki, Yuki Nakajima, Kenichi Utano, Kana Tamazawa, Kenta Ueda, Jun Wada, Kentaro Sato, Goro Shibukawa, Noriko Tanaka, Kazutomo Togashi

Objectives: In inflammatory bowel disease therapy, thiopurines have been essential. However, several reports have investigated factors affecting thiopurine metabolism to date. This study investigated factors affecting intracellular concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methylmercaptopurine (6-MMP) in a real-world setting.

Methods: Between May 2013 and October 2021 in one institution, 44 patients (median age 44 years;male 35, female 9;ulcerative colitis 32, Crohn's disease 12) receiving thiopurines were reviewed. Intracellular 6-TGN/6-MMP concentrations were measured by high-performance liquid chromatography, and the initial measurement in each patient was used for the study.

Results: The 6-TGN level was significantly higher in females, with mild disease activity, absence of NUDT15 polymorphism, and allopurinol administration. A higher trend was observed with high thiopurine dosage (>50 mg). 6-MMP levels were significantly lower with concomitant use of time-dependent 5-aminosalicylic acid (5-ASA) and allopurinol, and higher with high thiopurine dosage. On multivariate analysis of variance, logarithmically transformed 6-TGN levels were significantly higher in females, with high thiopurine dosage, and allopurinol administration. Similarly, logarithmically transformed 6-MMP levels were significantly higher with time-dependent 5-ASA administration and high thiopurine dosage.

Conclusions: Patients who received allopurinol, a high dose of thiopurine, or were female showed higher 6-TGN levels.

目的:在炎症性肠病治疗中,硫嘌呤是必不可少的。然而,迄今为止,有几篇报道调查了影响硫嘌呤代谢的因素。本研究在现实环境中研究了影响细胞内6-硫鸟嘌呤核苷酸(6-TGN)和6-甲基巯基嘌呤(6-MMP)浓度的因素。方法:回顾2013年5月至2021年10月在一家机构接受硫嘌呤治疗的44例患者(中位年龄44岁,男35岁,女9岁,溃疡性结肠炎32例,克罗恩病12例)。采用高效液相色谱法测定细胞内6-TGN/6-MMP浓度,并采用每位患者的初始测定值进行研究。结果:6-TGN水平在女性中明显升高,疾病活动度轻微,没有NUDT15多态性,且给予别嘌呤醇。高硫嘌呤剂量(bbb50 mg)有较高的趋势。同时使用时间依赖性5-氨基水杨酸(5-ASA)和别嘌呤醇时,6-MMP水平显著降低,高硫嘌呤剂量时,6-MMP水平升高。在多变量方差分析中,对数转换后的6-TGN水平在女性中显著升高,且硫嘌呤和别嘌呤醇的剂量较高。同样,随着时间依赖性的5-ASA和高硫嘌呤剂量的使用,对数转换后的6-MMP水平显著升高。结论:接受别嘌呤醇、高剂量硫嘌呤或女性患者的6-TGN水平较高。
{"title":"Therapeutic Agents and Patient Characteristics Affecting Metabolism of Thiopurines in Patients with Inflammatory Bowel Disease.","authors":"Masato Aizawa, Kohei Suzuki, Yuki Nakajima, Kenichi Utano, Kana Tamazawa, Kenta Ueda, Jun Wada, Kentaro Sato, Goro Shibukawa, Noriko Tanaka, Kazutomo Togashi","doi":"10.5387/fms.24-00009","DOIUrl":"10.5387/fms.24-00009","url":null,"abstract":"<p><strong>Objectives: </strong>In inflammatory bowel disease therapy, thiopurines have been essential. However, several reports have investigated factors affecting thiopurine metabolism to date. This study investigated factors affecting intracellular concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methylmercaptopurine (6-MMP) in a real-world setting.</p><p><strong>Methods: </strong>Between May 2013 and October 2021 in one institution, 44 patients (median age 44 years;male 35, female 9;ulcerative colitis 32, Crohn's disease 12) receiving thiopurines were reviewed. Intracellular 6-TGN/6-MMP concentrations were measured by high-performance liquid chromatography, and the initial measurement in each patient was used for the study.</p><p><strong>Results: </strong>The 6-TGN level was significantly higher in females, with mild disease activity, absence of NUDT15 polymorphism, and allopurinol administration. A higher trend was observed with high thiopurine dosage (>50 mg). 6-MMP levels were significantly lower with concomitant use of time-dependent 5-aminosalicylic acid (5-ASA) and allopurinol, and higher with high thiopurine dosage. On multivariate analysis of variance, logarithmically transformed 6-TGN levels were significantly higher in females, with high thiopurine dosage, and allopurinol administration. Similarly, logarithmically transformed 6-MMP levels were significantly higher with time-dependent 5-ASA administration and high thiopurine dosage.</p><p><strong>Conclusions: </strong>Patients who received allopurinol, a high dose of thiopurine, or were female showed higher 6-TGN levels.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"47-55"},"PeriodicalIF":0.7,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug resistance of Pseudomonas aeruginosa based on the isolation sites and types of gastrointestinal diseases: An observational study. 基于分离部位和胃肠道疾病类型的铜绿假单胞菌耐药性的观察性研究
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 Epub Date: 2024-12-18 DOI: 10.5387/fms.24-00019
Hironori Tsujimoto, Yuji Fujikura, Taka-Aki Hamamoto, Hiroyuki Horiguchi, Risa Takahata, Yusuke Ishibashi, Takao Sugihara, Keita Kouzu, Yujiro Itazaki, Sei-Ichiro Fujishima, Koichi Okamoto, Yoshiki Kajiwara, Susumu Matsukuma, Hideki Ueno

Introduction: We investigated the drug resistance status of Pseudomonas aeruginosa (P. aeruginosa) focusing on its isolation sites and types of diseases. Materials and methods: A microbiological laboratory database was searched to identify all clinical cultures positive for P. aeruginosa. Clinicopathologic features and susceptibility of P. aeruginosa to any antibiotics were evaluated in patients admitted to the division of upper (Upper-GI group) or lower gastrointestinal surgery (Lower-GI group). In addition, we investigated the susceptibility of P. aeruginosa to any antibiotics based on the isolation site. Results:P. aeruginosa was frequently detected in the sputum and urine of the Upper-GI and Lower-GI groups, respectively. Among P. aeruginosa isolates from drain discharge, a significantly higher rate of resistance to imipenem, amikacin, and ciprofloxacin was observed; among P. aeruginosa isolates from wounds, a substantially higher proportion had resistance to imipenem and cefozopran in the Upper-GI group. However, there was no difference between the two groups in the drug resistance of P. aeruginosa isolated from urine, sputum, blood, and ascites. P. aeruginosa isolated from sputum showed more resistance to imipenem and ciprofloxacin than those isolated from other sites. Conclusion: There were significant differences in the drug resistance of P. aeruginosa based on the isolation sites and types of diseases. .

摘要:我们对铜绿假单胞菌(Pseudomonas aeruginosa, P. aeruginosa)的耐药现状进行了调查,重点分析了其分离位点和疾病类型。材料和方法:检索微生物实验室数据库,以确定所有临床培养阳性铜绿假单胞菌。对上消化道组(上消化道组)和下消化道组(下消化道组)住院患者的临床病理特征和铜绿假单胞菌对任何抗生素的敏感性进行评估。此外,我们还根据分离位点调查了铜绿假单胞菌对各种抗生素的敏感性。结果:P。上gi组和低gi组的痰和尿中分别检出铜绿脓杆菌。铜绿假单胞菌对亚胺培南、阿米卡星和环丙沙星的耐药率较高;在伤口分离的铜绿假单胞菌中,上消化道组对亚胺培南和头孢唑普兰耐药的比例明显更高。然而,两组在尿液、痰液、血液和腹水中分离的铜绿假单胞菌的耐药性没有差异。痰中分离的铜绿假单胞菌对亚胺培南和环丙沙星的耐药性高于其他部位。结论:铜绿假单胞菌的耐药情况因分离部位和疾病类型的不同而有显著差异。
{"title":"Drug resistance of Pseudomonas aeruginosa based on the isolation sites and types of gastrointestinal diseases: An observational study.","authors":"Hironori Tsujimoto, Yuji Fujikura, Taka-Aki Hamamoto, Hiroyuki Horiguchi, Risa Takahata, Yusuke Ishibashi, Takao Sugihara, Keita Kouzu, Yujiro Itazaki, Sei-Ichiro Fujishima, Koichi Okamoto, Yoshiki Kajiwara, Susumu Matsukuma, Hideki Ueno","doi":"10.5387/fms.24-00019","DOIUrl":"10.5387/fms.24-00019","url":null,"abstract":"<p><strong>Introduction: </strong>We investigated the drug resistance status of Pseudomonas aeruginosa (P. aeruginosa) focusing on its isolation sites and types of diseases. Materials and methods: A microbiological laboratory database was searched to identify all clinical cultures positive for P. aeruginosa. Clinicopathologic features and susceptibility of P. aeruginosa to any antibiotics were evaluated in patients admitted to the division of upper (Upper-GI group) or lower gastrointestinal surgery (Lower-GI group). In addition, we investigated the susceptibility of P. aeruginosa to any antibiotics based on the isolation site. Results:P. aeruginosa was frequently detected in the sputum and urine of the Upper-GI and Lower-GI groups, respectively. Among P. aeruginosa isolates from drain discharge, a significantly higher rate of resistance to imipenem, amikacin, and ciprofloxacin was observed; among P. aeruginosa isolates from wounds, a substantially higher proportion had resistance to imipenem and cefozopran in the Upper-GI group. However, there was no difference between the two groups in the drug resistance of P. aeruginosa isolated from urine, sputum, blood, and ascites. P. aeruginosa isolated from sputum showed more resistance to imipenem and ciprofloxacin than those isolated from other sites. Conclusion: There were significant differences in the drug resistance of P. aeruginosa based on the isolation sites and types of diseases. .</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"25-34"},"PeriodicalIF":0.7,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacologic background and clinical issue of anti-influenza drugs. 抗流感药物的药理学背景及临床问题。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 Epub Date: 2024-12-18 DOI: 10.5387/fms.24-00029
Masatoki Sato

Since 2000, rapid antigen detection kits and anti-influenza drugs have been used for the early diagnosis and treatment of influenza in Japan, respectively. The main drugs available in clinical practice are the neuraminidase inhibitors oseltamivir, zanamivir, laninamivir, and peramivir, as well as the cap-dependent endonuclease inhibitor baloxavir marboxil. Antiviral therapy with neuraminidase inhibitors has been practiced for many years, especially in Japan; it can shorten the febrile period and reduce complications. Despite having similar structures, the pharmacologic background of neuraminidase inhibitors differs significantly, as reflected in their varying clinical efficacy. Due to its inhibitory mechanism, baloxavir marboxil can rapidly reduce the viral load than neuraminidase inhibitors. However, the duration of symptoms was similar after the administration of baloxavir marboxil and oseltamivir, and variants with reduced drug susceptibility have been detected in 20%-30% of pediatric patients treated with baloxavir marboxil. Clinical trials of several novel anti-influenza drugs are currently underway. When these drugs are first marketed, the characteristics of the influenza virus and the pharmacologic background of the drugs must be clarified before their administration to patients in clinical practice.

自2000年以来,日本分别将快速抗原检测试剂盒和抗流感药物用于流感的早期诊断和治疗。临床使用的主要药物是神经氨酸酶抑制剂奥司他韦、扎那米韦、拉那米韦和帕拉米韦,以及帽依赖性核酸内切酶抑制剂巴洛韦。使用神经氨酸酶抑制剂进行抗病毒治疗已有多年历史,特别是在日本;可缩短发热期,减少并发症。尽管具有相似的结构,但神经氨酸酶抑制剂的药理学背景差异很大,这反映在它们不同的临床疗效上。由于其抑制机制,baloxavir marboxil比神经氨酸酶抑制剂能迅速降低病毒载量。然而,在给予巴洛韦马博西和奥司他韦后,症状持续时间相似,并且在接受巴洛韦马博西治疗的20%-30%的儿科患者中检测到药物敏感性降低的变异。几种新型抗流感药物的临床试验正在进行中。当这些药物首次上市时,在临床实践中给病人使用之前,必须澄清流感病毒的特征和药物的药理学背景。
{"title":"Pharmacologic background and clinical issue of anti-influenza drugs.","authors":"Masatoki Sato","doi":"10.5387/fms.24-00029","DOIUrl":"10.5387/fms.24-00029","url":null,"abstract":"<p><p>Since 2000, rapid antigen detection kits and anti-influenza drugs have been used for the early diagnosis and treatment of influenza in Japan, respectively. The main drugs available in clinical practice are the neuraminidase inhibitors oseltamivir, zanamivir, laninamivir, and peramivir, as well as the cap-dependent endonuclease inhibitor baloxavir marboxil. Antiviral therapy with neuraminidase inhibitors has been practiced for many years, especially in Japan; it can shorten the febrile period and reduce complications. Despite having similar structures, the pharmacologic background of neuraminidase inhibitors differs significantly, as reflected in their varying clinical efficacy. Due to its inhibitory mechanism, baloxavir marboxil can rapidly reduce the viral load than neuraminidase inhibitors. However, the duration of symptoms was similar after the administration of baloxavir marboxil and oseltamivir, and variants with reduced drug susceptibility have been detected in 20%-30% of pediatric patients treated with baloxavir marboxil. Clinical trials of several novel anti-influenza drugs are currently underway. When these drugs are first marketed, the characteristics of the influenza virus and the pharmacologic background of the drugs must be clarified before their administration to patients in clinical practice.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"1-12"},"PeriodicalIF":0.7,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of Fecal Calprotectin Measurement in a Pediatric Patient with Crohn's Disease. 儿科克罗恩病患者粪便钙保护蛋白测定的意义。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 Epub Date: 2025-01-07 DOI: 10.5387/fms.23-00005
Shota Inoue, Kana Ito, Kiyotaka Zaha, Yusuke Yoshida, Yujin Sekinaka, Yoichi Kawamura

Acute pancreatitis in children in Japan is often caused by an anatomical abnormality of the pancreatic and bile duct, resulting in fever, abdominal pain, vomiting, diarrhea, and other symptoms. Crohn's disease, however, is a chronic granulomatous inflammatory bowel disease with ulcerative lesions of the intestinal tract of unknown cause that occurs mainly in young people, with symptoms similar to those of acute pancreatitis. We report a case of acute pancreatitis diagnosed in a patient not only with incomplete fusion of the pancreatic duct but also with Crohn's disease. A 14-year-old girl, healthy by nature, presented to our hospital with complaints of abdominal pain and diarrhea. She was initially diagnosed as having acute pancreatitis due to incomplete pancreas divisum. However, a high level of fecal calprotectin led to endoscopic examination, which resulted in the diagnosis of Crohn's disease. Fecal calprotectin can be useful in the diagnosis of inflammatory bowel disease associated with acute pancreatitis in children. Although the relationship between inflammatory bowel disease and acute pancreatitis has not yet been clarified, we suggest that in the present case, acute pancreatitis may have manifested as a complication of Crohn's disease and an underlying case of incomplete pancreas divisum.

日本儿童的急性胰腺炎通常是由胰腺和胆管的解剖异常引起的,导致发烧、腹痛、呕吐、腹泻等症状。然而,克罗恩病是一种慢性肉芽肿性炎症性肠病,主要发生在年轻人肠道中,原因不明,症状与急性胰腺炎相似。我们报告一个病例的急性胰腺炎诊断的病人不仅与胰管不完全融合,但也与克罗恩病。一名14岁女童,身体健康,以腹痛、腹泻主诉来我院就诊。她最初被诊断为急性胰腺炎,原因是胰腺分裂不完全。然而,高水平的粪便钙保护蛋白导致内窥镜检查,结果诊断为克罗恩病。粪便钙保护蛋白可用于诊断儿童急性胰腺炎相关的炎症性肠病。虽然炎症性肠病和急性胰腺炎之间的关系尚未明确,但我们认为,在本病例中,急性胰腺炎可能表现为克罗恩病的并发症和潜在的胰腺分裂不完全病例。
{"title":"Usefulness of Fecal Calprotectin Measurement in a Pediatric Patient with Crohn's Disease.","authors":"Shota Inoue, Kana Ito, Kiyotaka Zaha, Yusuke Yoshida, Yujin Sekinaka, Yoichi Kawamura","doi":"10.5387/fms.23-00005","DOIUrl":"10.5387/fms.23-00005","url":null,"abstract":"<p><p>Acute pancreatitis in children in Japan is often caused by an anatomical abnormality of the pancreatic and bile duct, resulting in fever, abdominal pain, vomiting, diarrhea, and other symptoms. Crohn's disease, however, is a chronic granulomatous inflammatory bowel disease with ulcerative lesions of the intestinal tract of unknown cause that occurs mainly in young people, with symptoms similar to those of acute pancreatitis. We report a case of acute pancreatitis diagnosed in a patient not only with incomplete fusion of the pancreatic duct but also with Crohn's disease. A 14-year-old girl, healthy by nature, presented to our hospital with complaints of abdominal pain and diarrhea. She was initially diagnosed as having acute pancreatitis due to incomplete pancreas divisum. However, a high level of fecal calprotectin led to endoscopic examination, which resulted in the diagnosis of Crohn's disease. Fecal calprotectin can be useful in the diagnosis of inflammatory bowel disease associated with acute pancreatitis in children. Although the relationship between inflammatory bowel disease and acute pancreatitis has not yet been clarified, we suggest that in the present case, acute pancreatitis may have manifested as a complication of Crohn's disease and an underlying case of incomplete pancreas divisum.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"57-61"},"PeriodicalIF":0.7,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024 Fukushima Medical University International Symposium on the Fukushima Health Management Survey -3.11: Sharing Lessons of Fukushima with Japan and the World. 2024福岛医科大学福岛健康管理调查国际研讨会-3.11:与日本和世界分享福岛经验。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 Epub Date: 2024-12-07 DOI: 10.5387/fms.24-00058
Rie Mizuki, Seiji Yasumura

Fukushima Medical University (FMU) organizes annual International Symposiums on the Fukushima Health Management Survey (FHMS) to share up-to-date Survey findings. In response to radiation released from the Tokyo Electric Power Company's Fukushima Daiichi Nuclear Power Plant after the Great East Japan Earthquake, the FHMS was established with the aim of providing long-term follow-up for the physical and mental health of Fukushima residents, and maintaining and improving their health into the future. This year, the sixth annual symposium was convened in Tokyo on Saturday, March 2, 2024, with the theme, "3.11:Sharing Lessons of Fukushima with Japan and the World."

福岛医科大学每年组织关于福岛健康管理调查(FHMS)的国际研讨会,以分享最新调查结果。为了应对东日本大地震后东京电力公司福岛第一核电站释放的辐射,建立了FHMS,目的是为福岛居民的身心健康提供长期随访,并在未来保持和改善他们的健康。今年,第六届年度研讨会于2024年3月2日星期六在东京召开,主题是“3.11:与日本和世界分享福岛的教训”。
{"title":"2024 Fukushima Medical University International Symposium on the Fukushima Health Management Survey -3.11: Sharing Lessons of Fukushima with Japan and the World.","authors":"Rie Mizuki, Seiji Yasumura","doi":"10.5387/fms.24-00058","DOIUrl":"10.5387/fms.24-00058","url":null,"abstract":"<p><p>Fukushima Medical University (FMU) organizes annual International Symposiums on the Fukushima Health Management Survey (FHMS) to share up-to-date Survey findings. In response to radiation released from the Tokyo Electric Power Company's Fukushima Daiichi Nuclear Power Plant after the Great East Japan Earthquake, the FHMS was established with the aim of providing long-term follow-up for the physical and mental health of Fukushima residents, and maintaining and improving their health into the future. This year, the sixth annual symposium was convened in Tokyo on Saturday, March 2, 2024, with the theme, \"3.11:Sharing Lessons of Fukushima with Japan and the World.\"</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"69-72"},"PeriodicalIF":0.7,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Fukushima Journal of Medical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1